{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:43:31Z","timestamp":1789710211352,"version":"4.0.1"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,25]]},"DOI":"10.18632\/oncotarget.11951","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T20:01:53Z","timestamp":1473537713000},"page":"69760-69769","source":"Crossref","is-referenced-by-count":46,"title":["Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation"],"prefix":"10.18632","volume":"7","author":[{"given":"Aoli","family":"Wang","sequence":"first","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"University of Science and Technology of China, Anhui, Hefei 230036, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-E","family":"Yan","sequence":"additional","affiliation":[{"name":"Institute of Systems Biomedicine, Department of Biophysics, Beijing Key Laboratory of Tumor Systems Biology and Center for Molecular and Translational Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"University of Science and Technology of China, Anhui, Hefei 230036, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Wang","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"Hefei Science Center, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"University of Science and Technology of China, Anhui, Hefei 230036, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"University of Science and Technology of China, Anhui, Hefei 230036, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"Hefei Science Center, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Systems Biomedicine, Department of Biophysics, Beijing Key Laboratory of Tumor Systems Biology and Center for Molecular and Translational Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixiang","family":"Li","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"University of Science and Technology of China, Anhui, Hefei 230036, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Wang","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"University of Science and Technology of China, Anhui, Hefei 230036, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Ye","sequence":"additional","affiliation":[{"name":"Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Wang","sequence":"additional","affiliation":[{"name":"Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center of Cancer Medicine, National Institute of Biological Sciences, Beijing 102206, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen L.","family":"Weisberg","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[{"name":"Collaborative Innovation Center of Cancer Medicine, National Institute of Biological Sciences, Beijing 102206, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"Hefei Science Center, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Hong","family":"Yun","sequence":"additional","affiliation":[{"name":"Institute of Systems Biomedicine, Department of Biophysics, Beijing Key Laboratory of Tumor Systems Biology and Center for Molecular and Translational Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Liu","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"},{"name":"University of Science and Technology of China, Anhui, Hefei 230036, P. R. China"},{"name":"Hefei Science Center, Chinese Academy of Sciences, Anhui, Hefei 230031, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cmdc.200600221","article-title":"Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase","volume":"2","author":"Honigberg","year":"2007","journal-title":"Chem Med Chem"},{"key":"2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton's tyrosine kinase in B cell malignancies","volume":"14","author":"Kil","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Radford","year":"2013","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Heerema","year":"2013","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1158\/1078-0432.CCR-14-0010","article-title":"Ibrutinib for the treatment of mantle cell lymphoma","volume":"20","author":"Jacobsen","year":"2014","journal-title":"Clin Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2013-07-515361","article-title":"Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)","volume":"123","author":"Gobessi","year":"2014","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/bjh.13149","article-title":"Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT, BCL2 pathways","volume":"168","author":"Hsi","year":"2015","journal-title":"Br J Haematol"},{"key":"8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood-2013-06-511154","article-title":"Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia","volume":"123","author":"MacEwan","year":"2014","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cellsig.2012.09.008","article-title":"BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-kappaB","volume":"25","author":"MacEwan","year":"2013","journal-title":"Cell Signal"},{"key":"10","first-page":"106","article-title":"Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells","author":"Hofstetter","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"11","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Buggy","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nchembio.1582","article-title":"A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors","volume":"10","author":"Wang","year":"2014","journal-title":"Nat Chem Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science1108367","article-title":"Structural bioinformatics-based design of selective, irreversible kinase inhibitors","volume":"308","author":"Taunton","year":"2005","journal-title":"Science"},{"key":"14","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1073\/pnas.0511292103","article-title":"An efficient rapid system for profiling the cellular activities of molecular libraries","volume":"103","author":"Harig","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"15","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0709662105","article-title":"The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP","volume":"105","author":"Eck","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2006.05.013","article-title":"An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor","volume":"125","author":"Kuriyan","year":"2006","journal-title":"Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","article-title":"A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells","volume":"64","author":"Gilmer","year":"2004","journal-title":"Cancer Research"},{"key":"18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-13-0314","article-title":"Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC","volume":"3","author":"Karp","year":"2013","journal-title":"Cancer Discov"},{"key":"19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Jacobs","year":"2014","journal-title":"Cancer Discov"},{"key":"20","first-page":"285","article-title":"Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer","volume":"7","author":"Popat","year":"2014","journal-title":"Pharmgenomics Pers Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nature08622","article-title":"Novel mutant-selective EGFR kinase inhibitors against EGFR T790M","volume":"462","author":"Eck","year":"2009","journal-title":"Nature"},{"key":"22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1107\/S0907444906019949","article-title":"HKL-3000: the integration of data reduction and structure solution\u2014from diffraction images to an initial model in minutes","volume":"62","author":"Chruszcz","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"Read","year":"2007","journal-title":"J Appl Crystallogr"},{"key":"24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1107\/S0907444998003254","article-title":"Crystallography & NMR system: A new software suite for macromolecular structure determination","volume":"54","author":"Simonson","year":"1998","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Cowtan","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Oeffner","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"van Aalten","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:00:03Z","timestamp":1589292003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,10]]},"references-count":27,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2016,10,25]]}},"alternative-id":["11951","27626175"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11951","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,10]]}}}